Rosacea: Dermatologist Dr Sandra Lee Explains How You Can Minimize Symptoms
There are things those living with rosacea can do do minimize symptoms.
There are things those living with rosacea can do do minimize symptoms.
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
Patients treated with a topical JAK inhibitor experienced significant reductions in itch as early as day 7 and greater treatment success by week 12.
In the midst of the pandemic, the hunger for data and desire to provide swift information may have lowered the quality of research, investigators report, according to SciTechDaily.
Read MoreWomen’s Health provides the scoop on eczema from a few board-certified dermatologists, to find out how it appears on Black skin, and how it can be diagnosed and treated.
Read MoreResearchers from Trinity College Dublin have discovered a key mechanism underlying bacterial skin colonization in atopic dermatitis, they suggest in the journal Proceedings of the National Academy of Sciences.
Read MoreA presentation at this year’s virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals the disparities that exist for Black and Hispanic children when it comes to Atopic Dermatitis (AD), commonly known as eczema.
Read MoreVitamin D supplementation eased the symptoms experienced by children with severe atopic dermatitis, or eczema, in a recent randomized controlled trial published in Pharmacology Research & Perspectives.
Read MorePatients with eczema and their carers experience frustration managing a disease often seen as mundane but has significant psychosocial impact, according to Dermatology Advisor.
Read MoreResearchers may be able to provide a non-invasive alternative to skin biopsy to correctly distinguish between two highly inflammatory diseases, they suggest in a media release.
Read MoreThe US Food and Drug Administration (FDA) has approved Wynzora Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older, MC2 Therapeutics announces.
Read MoreAtopic eczema wasn’t tied to a significantly increased risk for most cancers, according to research from England and Denmark, MedPage Today reports.
Read MoreResearchers at the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute (VCHRI) have identified a key enzyme that contributes to eczema, which may lead to better treatment to prevent the skin disorder’s debilitating effects.
Read MoreAlthough three biologic agents are now approved for use in some children, experts hope the guidelines will prompt further research so children and their families will someday have an array of treatment options available, as adults with psoriasis do today, they note in Healio.
Read MoreSkin symptoms have an important impact on mental health, but other somatic diseases associated with psoriasis can cause even more harm to mental health, researchers suggest in JAMA Dermatology.
Read MoreA Mount Sinai research team has identified one of the mechanisms that establish the skin as a protective barrier, a breakthrough that is critical to understanding and treating common skin conditions including eczema and psoriasis, according to a study published recently in Genes & Development.
Read MorePsoriasis has many treatment options, and an increasing number of cases are being treated with systemic medication. The safety of such medications is not well known, but a new study provides some safety data, Contemporary Pediatrics reports.
Read MoreHoth Therapeutics Inc announces that it has obtained exclusive worldwide licensing rights to the BioLexa Platform, a proprietary, patented antimicrobial therapy focused on treating atopic dermatitis.
Read More